Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2.

Abstract:

:Cancer cells recruit monocytes, macrophages and other inflammatory cells by producing abundant chemoattractants and growth factors, such as macrophage colony-stimulating factor (M-CSF/CSF-1) and monocyte chemoattractant protein-1 (MCP-1/CCL2), to promote tumor growth and dissemination. An understanding of the mechanisms that target cancer cells and regulate tumor microenvironment is essential in designing anticancer therapies. Here, we showed that serum amyloid-A (SAA) and cathelicidin (LL-37) stimulated M-CSF and MCP-1 expression with or without lipopolysaccharide (LPS) administration; conversely, lipoxin-A(4) (LXA(4)) and annexin-A1 (ANXA1) inhibited LPS-induced M-CSF and MCP-1 production by human (HepG2) and mouse (H22) hepatocellular carcinoma cells (HCCs). The effects of LXA(4), ANXA1, SAA and LL-37 were dependent on the activation of their mutual cell-surface receptor formyl peptide receptor-2 (FPR2) and subsequent ROS-MAPK-NF-kB signalings. Furthermore, our results indicated that LPS switched macrophages into an IL-10(low)IL-12(high) M1 profile, whereas M-CSF+MCP-1 and FPR2 agonists skewed them into M2 (IL-10(high)IL-12(low)). In that respect, through modulating the phosphorylation of signal transducer and activator of transcription-3 (STAT3), LXA(4) and ANXA1 induced monocyte differentiation into M2a+M2c-like cells and showed antitumorigenetic activities, whereas SAA, LL-37 and M-CSF+MCP-1 led to M2b- or M2d-like polarization, which exacerbated HCC invasion in vitro and in vivo, respectively. Our results suggest that FPR2 has an appreciable pleiotropic regulator role in tumor immunoediting.

journal_name

Oncogene

journal_title

Oncogene

authors

Li Y,Cai L,Wang H,Wu P,Gu W,Chen Y,Hao H,Tang K,Yi P,Liu M,Miao S,Ye D

doi

10.1038/onc.2011.112

subject

Has Abstract

pub_date

2011-09-08 00:00:00

pages

3887-99

issue

36

eissn

0950-9232

issn

1476-5594

pii

onc2011112

journal_volume

30

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Retrospective analysis of ras gene activation in myeloid leukemic cells.

    abstract::Ras genes are activated by point mutations at critical sites of their coding regions. Activated N-ras genes with transforming ability have been detected in patients with myelodysplastic syndromes (MDS), acute myelogenous leukemia (AML) and in human myeloid cell lines. We used polymerase chain reaction (PCR), different...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Lübbert M,Jonas D,Miller CW,Herrmann F,Mertelsmann R,McCormick F,Koeffler HP

    更新日期:1990-04-01 00:00:00

  • Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.

    abstract::The cysteine protease cathepsin B (CTSB) is frequently overexpressed in human breast cancer and correlated with a poor prognosis. Genetic deficiency or pharmacological inhibition of CTSB attenuates tumor growth, invasion and metastasis in mouse models of human cancers. CTSB is expressed in both cancer cells and cells ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.395

    authors: Bengsch F,Buck A,Günther SC,Seiz JR,Tacke M,Pfeifer D,von Elverfeldt D,Sevenich L,Hillebrand LE,Kern U,Sameni M,Peters C,Sloane BF,Reinheckel T

    更新日期:2014-09-04 00:00:00

  • Developmental expression of pim kinases suggests functions also outside of the hematopoietic system.

    abstract::We have cloned a novel quail cDNA with strong homology to the pim family of proto-oncogenes. The deduced amino acid (aa) sequence of the cDNA, named qpim, is more closely related to Xenopus Pim and to the recently identified rat Pim-3 than to human or rodent Pim-1 or Pim-2. The protein encoded by the qpim cDNA can aut...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203355

    authors: Eichmann A,Yuan L,Bréant C,Alitalo K,Koskinen PJ

    更新日期:2000-02-24 00:00:00

  • Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples.

    abstract::In order to elucidate the molecular mechanism(s) for BCL6 translocation, we identified translocational partner genes by subjecting clinical biopsy samples from patients with non-Hodgkin's lymphoma to 5'-rapid amplification of cDNA ends (5'-RACE). Sequence analysis of the 5'-RACE product revealed that the BCL6 gene was...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203293

    authors: Yoshida S,Kaneita Y,Aoki Y,Seto M,Mori S,Moriyama M

    更新日期:1999-12-23 00:00:00

  • COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.

    abstract::Biomarkers that predict disease progression might assist the development of better therapeutic strategies for aggressive cancers, such as ovarian cancer. Here, we investigated the role of collagen type XI alpha 1 (COL11A1) in cell invasiveness and tumor formation and the prognostic impact of COL11A1 expression in ovar...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.307

    authors: Wu YH,Chang TH,Huang YF,Huang HD,Chou CY

    更新日期:2014-06-26 00:00:00

  • A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design.

    abstract::Proliferating cell nuclear antigen (PCNA) has no intrinsic enzymatic function, but functions as a sliding platform to mediate protein interactions with the DNA strand. Many proteins interact with PCNA through a small conserved motif with consensus QxxLxxFF. This work uses Schizosaccharomyces pombe and human cells to a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209320

    authors: Warbrick E

    更新日期:2006-05-11 00:00:00

  • The amino-terminus of the E2F-1 transcription factor inhibits DNA replication of autonomously replicating plasmids in mammalian cells.

    abstract::The E2F1 transcription factor plays a pivotal role in driving cells out of a quiescent state and into the S phase of the cell cycle, in part by transactivating genes needed for DNA replication including DHFR, thymidine kinase, and DNA Polymerase alpha. E2F1 has also been implicated in regulating an S phase checkpoint,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205473

    authors: Stubbs MC,Hall DJ

    更新日期:2002-05-23 00:00:00

  • RNA polymerase III transcription and cancer.

    abstract::RNA polymerase (pol) III synthesizes a range of essential products, including tRNA, 5S rRNA and 7SL RNA, which are required for protein synthesis and trafficking. High rates of pol III transcription are necessary for cells to sustain growth. A wide range of transformed and tumour cell types have been shown to express ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207547

    authors: White RJ

    更新日期:2004-04-19 00:00:00

  • Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis.

    abstract::Protein phosphatase inhibitors are often considered as tumor promoters. Protein phosphatase 1 regulatory subunit 1A (PPP1R1A) is a potent protein phosphatase 1 (PP1) inhibitor; however, its role in tumor development is largely undefined. Here we characterize, for the first time, the functions of PPP1R1A in Ewing sarco...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.378

    authors: Luo W,Xu C,Ayello J,Dela Cruz F,Rosenblum JM,Lessnick SL,Cairo MS

    更新日期:2018-02-08 00:00:00

  • Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system.

    abstract::Beta-catenin and plakoglobin are closely related armadillo family proteins with shared and distinct properties; Both are associated with cadherins in actin-containing adherens junctions. Plakoglobin is also found in desmosomes where it anchors intermediate filaments to the desmosomal plaques. Beta-catenin, on the othe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203519

    authors: Sadot E,Simcha I,Iwai K,Ciechanover A,Geiger B,Ben-Ze'ev A

    更新日期:2000-04-13 00:00:00

  • Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation.

    abstract::Maspin has been demonstrated to be a suppressor of invasion and cell motility in vitro, whereas in vivo analyses have reported that increased expression of maspin is associated with malignant behavior. The present study examined maspin expression in normal lung and non-small-cell lung cancers. Only proximal airway cel...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207557

    authors: Yatabe Y,Mitsudomi T,Takahashi T

    更新日期:2004-05-20 00:00:00

  • Analysis of a variant Max sequence expressed in Xenopus laevis.

    abstract::Max is a small helix-loop-helix protein which forms heterodimers with members of the Myc protein family. Myc/Max heterodimers exhibit sequence-specific DNA binding with much greater affinity than Myc homodimers. The Xenopus laevis homologue of Max, XMax, is shorter than the equivalent mammalian protein. This differenc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tonissen KF,Krieg PA

    更新日期:1994-01-01 00:00:00

  • Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.

    abstract::A two-stage (initiation and promotion) model of chemical transformation of mouse embryonic fibroblasts was used to elucidate the molecular mechanisms of tumor promotion in vitro. C3H10T1/2 cells which had been initiated with a subcarcinogenic dose (0.5 micrograms ml-1) of benzo[a]pyrene (B[a]P) were isolated after 12-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wu WS,Lin JK,Wu FY

    更新日期:1992-11-01 00:00:00

  • Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.

    abstract::Alternative splicing is a widespread process contributing to structural transcript variation and proteome diversity. In cancer, the splicing process is commonly disrupted, resulting in both functional and non-functional end-products. Cancer-specific splicing events are known to contribute to disease progression; howev...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2015.318

    authors: Sveen A,Kilpinen S,Ruusulehto A,Lothe RA,Skotheim RI

    更新日期:2016-05-12 00:00:00

  • Transcriptional regulation of A33 antigen expression by gut-enriched Krüppel-like factor.

    abstract::A33 antigen is a membrane-bound protein that is expressed only in intestinal epithelium and in most human colon cancers. Thus, A33 antigen has been explored as a potential therapeutic target for the treatment of colon cancers. However, little is known about the mechanism responsible for the tissue-specific pattern of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206508

    authors: Mao Z,Song S,Zhu Y,Yi X,Zhang H,Shang Y,Tong T

    更新日期:2003-07-10 00:00:00

  • Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.

    abstract::Targeted therapeutics, such as those abrogating hypoxia inducible factor (HIF)/vascular endothelial growth factor signaling, are initially effective against kidney cancer (or renal cell carcinoma, RCC); however, drug resistance frequently occurs via subsequent activation of alternative pathways. Through genome-scale i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.510

    authors: Chen CH,Fong LWR,Yu E,Wu R,Trott JF,Weiss RH

    更新日期:2017-06-22 00:00:00

  • PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.

    abstract::Pancreatic cancer is characterized by early metastatic spread, but the process of tumor cell dissemination is largely unknown. In this study we show that the soluble protein pancreatic adenocarcinoma upregulated factor (PAUF) has an important role in the metastasis and progression of the disease. Variations in the lev...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.298

    authors: Lee Y,Kim SJ,Park HD,Park EH,Huang SM,Jeon SB,Kim JM,Lim DS,Koh SS

    更新日期:2010-01-07 00:00:00

  • Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.

    abstract::Rearrangements of the NFKB2 gene are associated with lymphoid malignancies, but the functional significance of these alterations is not known. Here we characterize structurally and functionally a rearranged NFKB2 gene identified at the T cell lymphoma line, HUT78. The rearrangement has truncated NFKB2 sequences within...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zhang J,Chang CC,Lombardi L,Dalla-Favera R

    更新日期:1994-07-01 00:00:00

  • Rearrangements of minisatellites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas.

    abstract::Telomerase activation is crucial in human carcinogenesis. The limiting component of telomerase, the catalytic subunit (hTERT), is undetectable in normal somatic cells but present in most tumor cells, including the earliest stages of colon carcinoma. The mechanisms involved in the differential expression in normal and ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204346

    authors: Szutorisz H,Palmqvist R,Roos G,Stenling R,Schorderet DF,Reddel R,Lingner J,Nabholz M

    更新日期:2001-05-03 00:00:00

  • The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma.

    abstract::The phosphatidylinositol 3'-kinase (PI3K) pathway is dysregulated in multiple myeloma (MM); we therefore tested a highly selective class I PI3K inhibitor, GDC-0941, for anti-myeloma activity. Functional and mechanistic studies were first performed in MM cell lines, then extended to primary MM patient samples cultured ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.594

    authors: Munugalavadla V,Mariathasan S,Slaga D,Du C,Berry L,Del Rosario G,Yan Y,Boe M,Sun L,Friedman LS,Chesi M,Leif Bergsagel P,Ebens A

    更新日期:2014-01-16 00:00:00

  • Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway.

    abstract::Syndecan-1 is a heparan sulfate proteoglycan (HSPG) commonly upregulated in AIDS-related B lymphoid malignancies. Tat is the main HIV-1 transactivating factor that has a major role in the pathogenesis of AIDS-related lymphomas (ARL) by engaging heparan sulfate proteoglycans (HSPGs), chemokine receptors and integrins a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.420

    authors: Urbinati C,Grillo E,Chiodelli P,Tobia C,Caccuri F,Fiorentini S,David G,Rusnati M

    更新日期:2017-05-04 00:00:00

  • Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival.

    abstract::Hedgehog pathway activity has been demonstrated in malignant glioma. However, its role in tumor growth has not been determined. Here we demonstrate that pharmacological inhibition of the Hedgehog pathway in established orthotopic malignant glioma xenografts confers a survival advantage. Pathway inhibition is measured ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.208

    authors: Sarangi A,Valadez JG,Rush S,Abel TW,Thompson RC,Cooper MK

    更新日期:2009-10-01 00:00:00

  • The regulatory roles of phosphatases in cancer.

    abstract::The relevance of potentially reversible post-translational modifications required for controlling cellular processes in cancer is one of the most thriving arenas of cellular and molecular biology. Any alteration in the balanced equilibrium between kinases and phosphatases may result in development and progression of v...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.80

    authors: Stebbing J,Lit LC,Zhang H,Darrington RS,Melaiu O,Rudraraju B,Giamas G

    更新日期:2014-02-20 00:00:00

  • Wild-type p53 gene transfer is not detrimental to normal cells in vivo: implications for tumor gene therapy.

    abstract::The p53 oncosuppressor is strictly maintained in an inactive form under normal conditions, while it is post-translationally activated by a variety of stresses, enacting different protective biological functions. Since one critical issue in cancer gene therapy is tumor specificity, we asked whether the tight p53 regula...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207042

    authors: Bossi G,Mazzaro G,Porrello A,Crescenzi M,Soddu S,Sacchi A

    更新日期:2004-01-15 00:00:00

  • Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation.

    abstract::Loss of Fanconi anemia (FA) proteins activity by recessive inherited mutations in one of the FA genes leads to a disease characterized by bone marrow failure, myeloid leukemia and DNA damage hypersensitivity. The aim of this work was to improve our understanding of the FA syndrome defining the transcription profile of...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207677

    authors: Zanier R,Briot D,Dugas du Villard JA,Sarasin A,Rosselli F

    更新日期:2004-06-24 00:00:00

  • The BPV-4 co-carcinogen quercetin induces cell cycle arrest and up-regulates transcription from the LCR of BPV-4.

    abstract::Bracken fern is the environmental co-carcinogen of BPV-4 in the induction of neoplasias of the upper alimentary canal of cattle. The flavonoid quercetin is one of the most potent and best characterised mutagens present in the fern. We have shown that transfection with BPV-4 DNA and exposure to a single dose of quercet...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201796

    authors: Connolly JA,Morgan IM,Jackson ME,Campo MS

    更新日期:1998-05-28 00:00:00

  • The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues.

    abstract::We previously showed that the proto-oncogene RON encodes the tyrosine kinase receptor for Macrophage Stimulating Protein (MSP), originally isolated as a chemotactic factor for peritoneal macrophages. To elucidate the biological role of MSP we studied the expression of the Ron receptor in vivo, and the response to the ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gaudino G,Avantaggiato V,Follenzi A,Acampora D,Simeone A,Comoglio PM

    更新日期:1995-12-21 00:00:00

  • Bcr-Abl induces autocrine IGF-1 signaling.

    abstract::Bcr-Abl oncogene is responsible for the initial phase of chronic myelogenous leukemia (CML), which is effectively treated by the Bcr-Abl inhibitor imatinib. Over time patients become resistant to treatment and progress to blast crisis, an event that is driven by additional genetic and epigenetic aberrations. Recently,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.8

    authors: Lakshmikuttyamma A,Pastural E,Takahashi N,Sawada K,Sheridan DP,DeCoteau JF,Geyer CR

    更新日期:2008-06-19 00:00:00

  • Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.

    abstract::Treatment with retinoic acid (RA) is effective to restore radioactive iodine uptake in metastases of a small fraction of thyroid cancer patients. In order to find predictive markers of response, we took advantage of two thyroid cancer cell lines, FTC133 and FTC238, with low RA-receptor (RAR)beta expression but differi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210178

    authors: Cras A,Darsin-Bettinger D,Balitrand N,Cassinat B,Soulié A,Toubert ME,Delva L,Chomienne C

    更新日期:2007-06-07 00:00:00

  • Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.

    abstract::MicroRNAs (miRNAs) have important roles in the initiation and progression of human cancer, but their role in head and neck cancer development and progression is not well defined. We aimed to determine whether specific miRNAs and their target mRNAs contribute to head and neck cancer pathogenesis and progression. To ide...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.13

    authors: Nakanishi H,Taccioli C,Palatini J,Fernandez-Cymering C,Cui R,Kim T,Volinia S,Croce CM

    更新日期:2014-02-06 00:00:00